RT Journal Article
T1 Cryoballoon Ablation for Persistent and Paroxysmal Atrial Fibrillation: Procedural Differences and Results from the Spanish Registry (RECABA).
A1 Vallès, Ermengol
A1 Jiménez, Jesús
A1 Martí-Almor, Julio
A1 Toquero, Jorge
A1 Ormaetxe, José Miguel
A1 Barrera, Alberto
A1 García-Alberola, Arcadio
A1 Rubio, José Manuel
A1 Moriña, Pablo
A1 Grande, Carlos
A1 Fé Arcocha, Maria
A1 Peinado, Rafael
A1 Cózar, Rocío
A1 Hernández, Julio
A1 Pérez-Alvarez, Luisa
A1 Gaztañaga, Larraitz
A1 Ferrero-De Loma-Osorio, Angel
A1 Ruiz-Granell, Ricardo
A1 Villuendas, Roger
A1 Martínez-Alday, Jesús Daniel
K1 cryoballoon procedure
K1 persistent atrial fibrillation
K1 registry
AB Introduction: Cryoballoon ablation (CBA) has become a standard treatment for paroxysmal atrial fibrillation (PaAF) but limited data is available for outcomes in patients with persistent atrial fibrillation (PeAF). Methods: We analyzed the first 944 patients included in the Spanish Prospective Multi-center Observation Post-market Registry to compare characteristics and outcomes of patients undergoing CBA for PeAF versus PaAF. Results: A total of 944 patients (57.8 ± 10.4 years; 70.1% male) with AF (27.9% persistent) were prospectively included from 25 centers. PeAF patients were more likely to have structural heart disease (67.7 vs. 11.4%; p
SN 2077-0383
YR 2022
FD 2022-02-22
LK http://hdl.handle.net/10668/21243
UL http://hdl.handle.net/10668/21243
LA en
DS RISalud
RD Apr 20, 2025